Nebenwirkungen · Betaferon
Betaferon 250 microgram/ml, powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 8
HOS-085145 · Präparat HOS-083087
System Organ Very common Common Uncommon Rare Frequency Class ( 1/10) ( 1/100 to ( 1/1,000 to ( 1/10,000 to not known < 1/10) < 1/100) < 1/1,000) Blood and Lymphocyte Lymphadenopathy, Thrombocytopenia Thrombotic Haemolytic lymphatic count decreased Anaemia microangiopathyd anaemiaa, d system (< 1500/mm3) e, including disorders White blood cell thrombotic count decreased thrombocytopenic (< 3000/mm3) e, purpura/ Absolute haemolytic neutrophil count uraemic decreased (< syndromeb 1500/mm3)e Immune system Anaphylactic Capillary disorders reactions leak syndrome in pre-existing monoclonal gammopathya Endocrine Hypothyroidism Hyperthyroidism, disorders Thyroid disorders Metabolism Weight increased, Blood triglycerides Anorexiaa and nutrition Weight decreased increased disorders Psychiatric Confusional state Suicide attempt Depression, disorders (see also section Anxiety 4.4), Emotional lability Nervous system Headache, Convulsion Dizziness disorders Insomnia
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2023-11-24T11:42:00Z · SHA-256 73002d6eb728583b13eb94f0947d2c951ea9003845f9750afc924bebe2f83959 · Passage 153cb5af58165aeadcc57d18e3772824eea332a27a5b983b517cbe78cd8ffffd · Zeichen 1736–4497 im Abschnitt